Interestingly, this mutant CaV1.2 channel function could be modulated by one anchoring protein AKAP150, elimination of which could abrogate the prolonged QT interval [71], implying AKAP150 may be a promising target for TS. The gene discussed is CACNA1C; the disease is Timothy syndrome.